Department of Breast Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China.
Oncol Rep. 2010 Jul;24(1):203-11. doi: 10.3892/or_00000847.
An ideal mouse model should closely mimic a clinical situation. However, for most models available, this is not the case since clinical trials frequently fail to reproduce the highly encouraging therapeutic results obtained from pre-clinical studies performed using mouse models. In this study, in the process of extending the application of our previously established breast tissue-derived orthotopic and metastatic (BOM) model, the human breast cancer cell line MDA-MB-231 failed to exhibit any osteotropic features that differed from previous studies. Our observations suggest that a human tissue-specific microenvironment could be an essential requirement for a successful mouse model of breast cancer. Here, multiple in vivo breast cancer models were used to confirm this hypothesis. Human breast tissue and cancellated bone were transplanted subcutaneously to female severe combined immunodeficiency disease (SCID) mice by different assemblies, to build several mouse models termed 'breast-breast', 'breast-bone', 'bone-bone', 'MFP (mouse mammary fat pad)-bone', and 'MFP-breast' models. Two human breast cancer cell lines, MDA-MB-231 and MDA-MB-231BO, and the mouse breast cancer cell line TM40D were used. All cancer cells were labeled with GFP for gross observation. In addition, transplanted human tissues and various mouse tissues including bone, lung, liver, mesentery were examined microscopically. Based on morphological, immunohistochemical, and enzymohistochemical evidence obtained from several comparative experiments in 'breast-breast', 'breast-bone' and 'bone-bone' models, the BOM model was proved to be feasible and reliable. The organ tropism of the breast cancer cell line, which was derived from a mouse model by intracardiac inoculation in a pure mouse microenvironment, was reconsidered. The behavior of breast cancer cells in the mouse model was altered in response to the varying microenvironment. The results in this study suggest the human tissue-specific micro-environment is most likely an essential requirement in mouse models of breast cancer.
理想的小鼠模型应密切模拟临床情况。然而,对于大多数可用的模型来说,情况并非如此,因为临床试验经常未能重现使用小鼠模型进行临床前研究获得的高度令人鼓舞的治疗结果。在这项研究中,在扩展我们之前建立的乳腺组织来源的原位和转移性(BOM)模型的应用过程中,人乳腺癌细胞系 MDA-MB-231 未能表现出与之前研究不同的任何嗜骨性特征。我们的观察结果表明,人类组织特异性微环境可能是成功建立乳腺癌小鼠模型的必要条件。在这里,使用多种体内乳腺癌模型来验证这一假设。通过不同的组合,将人乳腺组织和多孔骨移植到雌性重度联合免疫缺陷疾病(SCID)小鼠的皮下,构建了几种称为“乳腺-乳腺”、“乳腺-骨”、“骨-骨”、“MFP(鼠乳腺脂肪垫)-骨”和“MFP-乳腺”模型的小鼠模型。使用了两种人乳腺癌细胞系 MDA-MB-231 和 MDA-MB-231BO 以及小鼠乳腺癌细胞系 TM40D。所有癌细胞均用 GFP 标记进行大体观察。此外,还观察了移植的人组织和各种小鼠组织,包括骨、肺、肝、肠系膜。基于在“乳腺-乳腺”、“乳腺-骨”和“骨-骨”模型中进行的几个比较实验的形态学、免疫组织化学和酶组织化学证据,证明了 BOM 模型是可行和可靠的。从纯小鼠微环境中心内接种获得的源自小鼠模型的乳腺癌细胞系的器官嗜性被重新考虑。乳腺癌细胞在小鼠模型中的行为因微环境的变化而发生改变。本研究的结果表明,人类组织特异性微环境很可能是乳腺癌小鼠模型的必要条件。